{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:48:01Z","timestamp":1790801281452,"version":"4.1.0"},"reference-count":130,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101734\/Z\/13\/Z"],"award-info":[{"award-number":["101734\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003522","name":"Crohn\u2019s and Colitis UK","doi-asserted-by":"publisher","award":["M\/13\/3"],"award-info":[{"award-number":["M\/13\/3"]}],"id":[{"id":"10.13039\/501100003522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01296","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T04:16:27Z","timestamp":1507868187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":155,"title":["Innate Lymphoid Cells in Intestinal Inflammation"],"prefix":"10.3389","volume":"8","author":[{"given":"Alessandra","family":"Geremia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina V.","family":"Arancibia-C\u00e1rcamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells \u2013 a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2010.10.012","article-title":"Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by toll-like receptor 2","volume":"33","author":"Crellin","year":"2010","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fimmu.2015.00416","article-title":"Maintenance of immune homeostasis through ILC\/T cell interactions","volume":"6","author":"Burg von","year":"2015","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/17812","article-title":"Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2","volume":"397","author":"Yokota","year":"1999","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.immuni.2014.01.012","article-title":"The transcription factor GATA3 is critical for the development of all IL-7R\u03b1-expressing innate lymphoid cells","volume":"40","author":"Yagi","year":"2014","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","article-title":"Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria","volume":"43","author":"Bernink","year":"2015","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","article-title":"A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells","volume":"494","author":"Klose","year":"2013","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20151750","article-title":"IL-12 drives functional plasticity of human group 2 innate lymphoid cells","volume":"213","author":"Lim","year":"2016","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ni.3094","article-title":"Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets","volume":"16","author":"Robinette","year":"2015","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ni.3368","article-title":"The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing","volume":"17","author":"Bj\u00f6rklund","year":"2016","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1006373","DOI":"10.1371\/journal.ppat.1006373","article-title":"Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy","volume":"13","author":"Kr\u00e4mer","year":"2017","journal-title":"PLoS Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.immuni.2012.09.008","article-title":"The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells","volume":"37","author":"Powell","year":"2012","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"10240","DOI":"10.1073\/pnas.1217158110","article-title":"Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells","volume":"110","author":"Klein Wolterink","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.immuni.2012.06.012","article-title":"Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation","volume":"37","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.2208","article-title":"Transcription factor ROR\u03b1 is critical for nuocyte development","volume":"13","author":"Wong","year":"2012","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.immuni.2012.12.003","article-title":"T cell factor 1 is required for group 2 innate lymphoid cell generation","volume":"38","author":"Yang","year":"2013","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/mi.2015.21","article-title":"The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung","volume":"8","author":"Wojno","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","article-title":"Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production","volume":"132","author":"Doherty","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mj\u00f6sberg","year":"2012","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.4049\/jimmunol.1301888","article-title":"Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice","volume":"192","author":"KleinJan","year":"2014","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1031\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"Molofsky","year":"2013","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.4049\/jimmunol.1301176","article-title":"Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice","volume":"191","author":"Hams","year":"2013","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nature08901","article-title":"IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses","volume":"464","author":"Saenz","year":"2010","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1084\/jem.20122332","article-title":"IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells","volume":"210","author":"Saenz","year":"2013","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/imr.12407","article-title":"Innate lymphoid cells in secondary lymphoid organs","volume":"271","author":"Bar-Ephra\u00efm","year":"2016","journal-title":"Immunol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.2187","article-title":"AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch","volume":"13","author":"Lee","year":"2011","journal-title":"Nat Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1126\/science.1214914","article-title":"Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles","volume":"334","author":"Kiss","year":"2011","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","article-title":"The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells","volume":"36","author":"Qiu","year":"2012","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11882-016-0652-3","article-title":"Dysregulation of group 3 innate lymphoid cells in the pathogenesis of inflammatory bowel disease","volume":"16","author":"Forkel","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e12436","DOI":"10.1111\/pim.12436","article-title":"Origins and evolution of innate lymphoid cells: Wardens of barrier immunity","volume":"5","author":"Neill","year":"2017","journal-title":"Parasite Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","article-title":"Innate lymphoid cells in inflammation and immunity","volume":"41","author":"McKenzie","year":"2014","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/eji.201545598","article-title":"Group 3 innate lymphoid cells (ILC3s): origin, differentiation, and plasticity in humans and mice","volume":"45","author":"Montaldo","year":"2015","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00281-013-0393-5","article-title":"Aryl hydrocarbon receptor promotes ROR\u03b3t+ group 3 ILCs and controls intestinal immunity and inflammation","volume":"35","author":"Qiu","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","article-title":"CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut","volume":"34","author":"Sonnenberg","year":"2011","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.immuni.2014.09.010","article-title":"Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage","volume":"41","author":"Hasegawa","year":"2014","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fimmu.2014.00142","article-title":"Recognition strategies of group 3 innate lymphoid cells","volume":"5","author":"Killig","year":"2014","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17\u2009cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1126\/science.1222551","article-title":"Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria","volume":"336","author":"Sonnenberg","year":"2012","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2015.01.011","article-title":"Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection","volume":"42","author":"Mu\u00f1oz","year":"2015","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature11535","article-title":"IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine","volume":"491","author":"Huber","year":"2012","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","article-title":"ROR\u03b3t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota","volume":"12","author":"Sawa","year":"2011","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.febslet.2014.03.034","article-title":"Development and regulation of ROR\u03b3t(+) innate lymphoid cells","volume":"588","author":"Cording","year":"2014","journal-title":"FEBS Lett"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","article-title":"Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells","volume":"348","author":"Hepworth","year":"2015","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1249288","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.2830","article-title":"Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells","volume":"15","author":"Magri","year":"2014","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.immuni.2008.05.014","article-title":"Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut","volume":"29","author":"Tsuji","year":"2008","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.15252\/embr.201642412","article-title":"CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production","volume":"18","author":"Saez de Guinoa","year":"2017","journal-title":"EMBO Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature13823","article-title":"Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness","volume":"514","author":"Pickard","year":"2014","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1254009","DOI":"10.1126\/science.1254009","article-title":"Innate lymphoid cells regulate intestinal epithelial cell glycosylation","volume":"345","author":"Goto","year":"2014","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ni.3587","article-title":"Epithelial glycosylation in gut homeostasis and inflammation","volume":"17","author":"Goto","year":"2016","journal-title":"Nat Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1586\/egh.11.107","article-title":"The IL-23\/IL-17 pathway in inflammatory bowel disease","volume":"6","author":"Geremia","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e10066","DOI":"10.7554\/eLife.10066","article-title":"ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation","volume":"5","author":"Pearson","year":"2016","journal-title":"Elife"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4049\/jimmunol.163.1.143","article-title":"Bioactive IL-18 expression is up-regulated in Crohn\u2019s disease","volume":"163","author":"Monteleone","year":"1999","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","article-title":"IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn\u2019s disease: expression and localization in intestinal mucosal cells","volume":"162","author":"Pizarro","year":"1999","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/00002371-200203001-00010","article-title":"Serum interleukin-18 concentrations in patients with inflammatory bowel disease","volume":"25","author":"Furuya","year":"2002","journal-title":"J Immunother"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J Exp Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"11","author":"Gwela","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0016-5085(97)70128-8","article-title":"Interleukin 12 is expressed and actively released by Crohn\u2019s disease intestinal lamina propria mononuclear cells","volume":"112","author":"Monteleone","year":"1997","journal-title":"Gastroenterology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00535-012-0591-2","article-title":"Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13","volume":"47","author":"Camelo","year":"2012","journal-title":"J Gastroenterol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaci.2015.05.048","article-title":"Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis","volume":"136","author":"Doherty","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn\u2019s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nri3896","article-title":"Emerging cytokine networks in colorectal cancer","volume":"15","author":"West","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20122308","article-title":"Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model","volume":"210","author":"Kirchberger","year":"2013","journal-title":"J Exp Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/mi.2013.101","article-title":"Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells","volume":"7","author":"Chan","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"B105","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.crohns.2014.01.019","article-title":"Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"8","author":"Ananthakrishnan","year":"2014","journal-title":"J Crohns Colitis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"B108","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.gastro.2010.05.040","article-title":"Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn\u2019s disease","volume":"139","author":"Takayama","year":"2010","journal-title":"Gastroenterology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2016.05.001","article-title":"The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn\u2019s disease","volume":"30","author":"Li","year":"2016","journal-title":"Cell Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bpg.2014.04.005","article-title":"Not all monoclonals are created equal \u2013 lessons from failed drug trials in Crohn\u2019s disease","volume":"28","author":"Kaser","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/mi.2008.28","article-title":"IL-23 and Th17 cytokines in intestinal homeostasis","volume":"1","author":"Maloy","year":"2008","journal-title":"Mucosal Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"13416","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"7","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2012-302525","article-title":"Seventeen in Crohn\u2019s disease: less prime than we thought?","volume":"61","author":"Raine","year":"2012","journal-title":"Gut"},{"key":"B119","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.chom.2010.01.006","article-title":"GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen","volume":"7","author":"Hirata","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ibd.20279","article-title":"Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis","volume":"14","author":"Sainathan","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2008.12.046","article-title":"Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn\u2019s disease","volume":"136","author":"Han","year":"2009","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa041109","article-title":"Sargramostim for active Crohn\u2019s disease","volume":"352","author":"Korzenik","year":"2005","journal-title":"N Engl J Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ibd.22973","article-title":"Sargramostim (GM-CSF) for induction of remission in Crohn\u2019s disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials","volume":"18","author":"Roth","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Anti-interleukin-12 antibody for active Crohn\u2019s disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn\u2019s disease","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","article-title":"A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis","volume":"365","author":"Reich","year":"2011","journal-title":"N Engl J Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(17)30570-6","article-title":"Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn\u2019s disease: a randomised, double-blind, placebo-controlled phase 2 study","volume":"389","author":"Feagan","year":"2017","journal-title":"Lancet"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/0016-5085(92)91722-G","article-title":"Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn\u2019s disease but not ulcerative colitis","volume":"102","author":"Mullin","year":"1992","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:19:11Z","timestamp":1693106351000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":130,"alternative-id":["10.3389\/fimmu.2017.01296"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01296","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]},"article-number":"1296"}}